Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health services strengthening in Africa--research is a key component.
Jaffar S, Lazarus JV, Onyebujoh P, Chakaya J, Garrib A, Mwaba P, Mboup S, Bellis K, Egwaga S, Corrah T, Coutinho A. Jaffar S, et al. Among authors: egwaga s. Trop Med Int Health. 2010 Nov;15(11):1270-3. doi: 10.1111/j.1365-3156.2010.02626.x. Epub 2010 Aug 19. Trop Med Int Health. 2010. PMID: 20731794 Free article. No abstract available.
Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.
Mfinanga S, Chanda D, Kivuyo SL, Guinness L, Bottomley C, Simms V, Chijoka C, Masasi A, Kimaro G, Ngowi B, Kahwa A, Mwaba P, Harrison TS, Egwaga S, Jaffar S; REMSTART trial team. Mfinanga S, et al. Among authors: egwaga s. Lancet. 2015 May 30;385(9983):2173-82. doi: 10.1016/S0140-6736(15)60164-7. Epub 2015 Mar 10. Lancet. 2015. PMID: 25765698 Clinical Trial.
Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial.
Mfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G, Ezechi O, Connolly C, Kapotwe V, Muwonge C, Massaga J, Sinkala E, Kohi W, Lyantumba L, Nyakoojo G, Luwaga H, Doulla B, Mzyece J, Kapata N, Vahedi M, Mwaba P, Egwaga S, Adatu F, Pym A, Joloba M, Rustomjee R, Zumla A, Onyebujoh P. Mfinanga SG, et al. Among authors: egwaga s. Lancet Infect Dis. 2014 Jul;14(7):563-71. doi: 10.1016/S1473-3099(14)70733-9. Epub 2014 May 5. Lancet Infect Dis. 2014. PMID: 24810491 Clinical Trial.
APOPO's tuberculosis research agenda: achievements, challenges and prospects.
Beyene N, Mahoney A, Cox C, Weetjens B, Makingi G, Mgode G, Durgin A, Kuipers D, Jubitana M, Egwaga S, Kamara D, Lwilla F, Mfinanga SG, Kahwa A, Machang'u R, Kazwala R, Reither K, Kaufmann SH, Poling A. Beyene N, et al. Among authors: egwaga s. Tanzan J Health Res. 2012 Apr;14(2):121-30. doi: 10.4314/thrb.v14i2.5. Tanzan J Health Res. 2012. PMID: 26591733
38 results